Scoop has an Ethical Paywall
Cancer Society Hopes Final Pharmac Report Is Stronger
Today the delayed Interim Report was released by the Pharmac Review Panel. The performance of Pharmac and access to cancer drugs is a major concern for the Cancer Society.
Lucy Elwood, CEO of the Cancer Society of New Zealand says:
“Every day we see the stress caused to patients and their whānau when time is running out, they are aware of drugs funded elsewhere (such as Australia) and are waiting for Pharmac to make a decision to fund.”
“This a major milestone in a review that is absolutely crucial – it is our first independent look at Pharmac's systems and processes since Pharmac was created over 25 years ago.”
“We sincerely hope the final report is stronger. In New Zealand there is an ever-growing chasm between those who can and cannot fund unfunded drugs. The inequity and financial toxicity for patients accessing treatments that are considered "standard of care" in comparable health care systems (like NHS in the UK) is huge and growing larger every day.”
University of Auckland: Tributes Flow For Much Loved Pacific Leader Melegalenu’u Ah Sam
NZEI: Ministry Of Education Cuts Will Disproportionately Affect Pasifika
Day One Hapai te Haeata: Call To Action For Young Filmmakers Against The Backdrop Of Funding Cuts
Toyota New Zealand: Three Races For Top Three To Decide TR86 Title
Wellington City Council: Wellington Is All Action Stations For The Faultline Ultra Festival
Melanie Allison: Local Playwright Casts A Spell Over Hamilton